GHK-Cu collagen and skin regeneration research
helps minimize skin from redness and inflammation
the "PDA counterion argument" for regulatory compliance has not been validated by FDA guidance as of April 2026
Cagrilintide monotherapy has the lowest treatment discontinuation rate of any major weight loss peptide in clinical trials
As one of the most studied recovery-focused research peptides in Australia, it is cited across connective tissue, tendon, and gut-model research
In 2024, Koniver was sanctioned by South Carolina public-health officials who found, among other things, that hed failed to maintain his registration with the Drug Enforcement Administration while prescribing controlled substances, and that hed neglected to check patient vital signs before administering ketamine